7 withdrawn. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Withdrawn 7 |
Follow Emergencies: new trials by email Literature Review of Emergencies trials Research Report on Emergencies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing in Dexmedetomidine With po/pr Midazolam for Procedural Sedation in the Pediatric Emergency Department Dexmedetomidine, Midazolam - Procedural Anxiety, Emergencies | Phase 4 | Withdrawn | Insel Gruppe AG, University Hospital Bern | 2023-08-01 | 2022-09-30 | |
| Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department Trigger point injection with 1% lidocaine, Lidocaine patch 5% - Myofascial Trigger Point Pain, Myofacial Pain | Phase 4 | Withdrawn | University of California, Irvine | 2021-11-01 | 2026-02-13 | |
| A RCT of a Combination of Analgesics for Pain Management in Children With a Suspected Fracture INF2.0 + IBU, INF1.0 + IBU - Emergency Service, Hospital, Child/Adolescent Problem | Phase 4 | Withdrawn | St. Justine's Hospital | 2020-01-01 | 2022-11-23 | |
| Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department Preventative Medication (PM), Enhanced Usual Care, PMR (progressive muscle relaxation therapy) - Migraine | Phase 4 | Withdrawn | NYU Langone Health | 2016-12-28 | 2019-11-29 | |
| Magnesium Sulfate to Prevent Hospitalisation of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Magnesium Sulfate, Placebo - Pulmonary Disease, Chronic Obstructive | Phase 4 | Withdrawn | Hôpital de Verdun | 2016-09-01 | 2018-02-22 | |
| Pain Management in ED for Incision and Drainage of Abscess Fentanyl, Normal Saline - Abscess | Phase 4 | Withdrawn | University of California, Los Angeles | 2011-06-01 | 2013-06-20 | |
| Pulmicort Respules on Relapse Rates After Treatment in the ED pulmicort respules - Asthma | Phase 4 | Withdrawn | Phoenix Children's Hospital | 2007-10-01 | 2026-01-23 |
Agnosia (3) · Abscess (1) · Acute Pain (1) · Asthma (1) · Facial Pain (1) · Migraine Disorders (1) · Myofascial Pain Syndromes (1) · Pulmonary Disease, Chronic Obstructive (1)
Disease Attributes (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Nervous System Diseases (4) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Perceptual Disorders (3) · Signs and Symptoms (3) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Pain (2) · Respiratory Tract Diseases (2) · Brain Diseases (1) · Bronchial Diseases (1) · Central Nervous System Diseases (1)
Saline Solution (2) · Budesonide (1) · Dexmedetomidine (1) · Fentanyl (1) · Lidocaine (1) · Magnesium Sulfate (1) · Midazolam (1) · Topiramate (1)
Hôpital de Verdun (1) · Insel Gruppe AG, University Hospital Bern (1) · NYU Langone Health (1) · Phoenix Children's Hospital (1) · St. Justine's Hospital (1) · University of California, Irvine (1) · University of California, Los Angeles (1)
United States (3) · Canada (1)
Adaira Landry, B.A. (1) · Ivan Pavlov, MD (1) · Jonathan Lee, MD (1) · Joshua W Elder, B.S. (1) · Julia Hoeffe, MD (1) · Katherine Mandeville, MD (1) · Larry J Baraff, MD (1) · Le May Sylvie, PhD (1) · Mia Minen, MD (1) · Robert B Bulloch, MD (1)
PMID 11555797, PMID 12487041, PMID 18090011, PMID 18826731, PMID 19388915, PMID 21063553, PMID 21197290, PMID 2803357, PMID 7862469, PMID 9491040